Skip to main content
Quest Diagnostics

Assessment of Known and Newly Discovered IGF-1 Variants by a High-throughput Clinical Reference Laboratory

AACC/ADLM 2024

The Association for Diagnostics & Laboratory Medicine (formerly ACC)

Chicago, IL, July 28-Aug 1, 2024

Poster presentation: Assessment of Known and Newly Discovered IGF-1 Variants by a High-throughput Clinical Reference Laboratory

Authors: Motorykin I, Li EM, Li H, McPhaul MJ, Clarke NJ, Wu Z

Specialty: Endocrinology, Cardiology

Related content

Publication
Isotopic Peak Index, Relative Retention Time, and Tandem MS for Automated High Throughput IGF-1 Variants Identification in a Clinical Laboratory
Publication
Detection Rate of IGF-1 Variants and Their Implication to Protein Binding: Study of Over 240,000 Patients
Conference Presentation
Detection of an unusual IGF-2 species using high-resolution mass spectrometry during a routine IGF-1 clinical assay

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.